Dueling for Duals: Why the Poorest Medicare Recipients Should be Pharma's Top Priority in 2006
This article was originally published in RPM Report
Executive Summary
The transfer of the poorest Medicare recipients to Part D means big changes in a critical submarket for pharma. If all goes well, it should pay off in a de facto price increase for some of the biggest industry blockbusters.